Basri Satılmış
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Basri Satılmış has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Sezai Yilmaz
Liver Transplant Institute, İnonu University, Malatya, Türkiye
8 shared publications - Tevfik Tolga Sahin
Department of Surgery and Liver Transplant Institute, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey
8 shared publications - Ayşe Burçin Uyumlu
İnönü Üniversitesi
4 shared publications - Sami Akbulut
Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye
4 shared publications - Adem Tuncer
Department of General Surgery, Florence Nightingale Hospital, Demiroğlu Bilim University, Istanbul 34365, Turkey
3 shared publications - Egemen Cicek
Department of General Surgery, Division of Gastroenterological Surgery, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye
3 shared publications
Latest Publications
- Open Access
- 13 March 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 657
Adipose-Derived Stem Cell Treatment Induces Early-Term Hes1 Upregulation in a Sox9- and Notch1-Independent Manner in a Rat Model of Bile Duct Ligation
Background/Objectives: Bile duct ligation (BDL), characterized by marked inflammation and fibrosis, effectively mimics many clinical conditions and is a valuable tool for investigating biliary regeneration. Our objective was to clarify the therapeutic benefits of adipose-derived stem cell (ADSC) treatment and signaling pathways mediating regenerative processes in a rat model of BDL. Methods: The BDL model was performed on Sprague–Dawley rats, and ADSC was administered intrasplenically at a dose of 106 cells per animal. Liver function tests, gene and protein expression analyses, histological evaluation, and immunohistochemistry staining were performed to assess liver function, signaling pathways, inflammation, and fibrosis. Results: ADSC treatment returned liver function to sham levels. ADSC upregulated the Hes1 gene and protein expression in the early and late term. Inflammation, fibrosis, and total damage scores were decreased following ADSC treatment compared with the control. Immunohistochemistry staining revealed higher CD90, CD44, and CD29 stem cell marker expression in the ADSC treatment group. Conclusions: ADSC administration reduced fibrosis and biliary damage and restored liver function, potentially in a manner mediated by upregulated Hes1 expression, supporting its promise in biliary regeneration.
- 13 March 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 657
Open AccessAdipose-Derived Stem Cell Treatment Induces Early-Term Hes1 Upregulation in a Sox9- and Notch1-Independent Manner in a Rat Model of Bile Duct Ligation
Background/Objectives: Bile duct ligation (BDL), characterized by marked inflammation and fibrosis, effectively mimics many clinical conditions and is a valuable tool for investigating biliary regeneration. Our objective was to clarify the therapeutic benefits of adipose-derived stem cell (ADSC) treatment and signaling pathways mediating regenerative processes in a rat model of BDL. Methods: The BDL model was performed on Sprague–Dawley rats, and ADSC was administered intrasplenically at a dose of 106 cells per animal. Liver function tests, gene and protein expression analyses, histological evaluation, and immunohistochemistry staining were performed to assess liver function, signaling pathways, inflammation, and fibrosis. Results: ADSC treatment returned liver function to sham levels. ADSC upregulated the Hes1 gene and protein expression in the early and late term. Inflammation, fibrosis, and total damage scores were decreased following ADSC treatment compared with the control. Immunohistochemistry staining revealed higher CD90, CD44, and CD29 stem cell marker expression in the ADSC treatment group. Conclusions: ADSC administration reduced fibrosis and biliary damage and restored liver function, potentially in a manner mediated by upregulated Hes1 expression, supporting its promise in biliary regeneration.
- Open Access
- 23 February 2026
- Published by Springer Nature in Research Square
Cytotoxic and Apoptotic Effects of Teucrium Polium L Extract on Human Hepatocellular Carcinoma Cell Line SNU-449
Purpose : The current study aims to evaluate the effects of T. polium extract on the human HCC cell line SNU-449 in vitro and to determine possible cytotoxic, apoptotic and anti-cancer properties. Methods : The MTT assay was performed to determine the dose-dependent effects of T. polium on tumor cell proliferation and to calculate IC50. The colony formation assay was carried out using the IC50 dose of T. polium to evaluate its effects on colony formation. To study the effect of T. polium on in vitro migration of SNU-449 cells, the scratch assay was performed. Finally, Western blotting was performed for caspase-3 and cleaved caspase-3 to study possible apoptotic effects. Results : MTT analysis results demonstrated a dose-dependent decrease in cell viability. IC50 was calculated as 90 μg/mL using measurements from the 48th hour results. The colony formation assay showed that colony formation efficiency was reduced by 50% among SNU-449 cells in the T. polium treated group. With the wound healing assay results, half-gap times for the T. polium treated group and the control group were determined as 50.5 and 28.5 hours, respectively. Comparison of the caspase-3 and cleaved caspase-3 levels measured in T. polium treated cells and control cells by means of Western blotting did not demonstrate a significant difference between the two groups. Conclusion : Reducing proliferation and survival rates in SNU-449 cells, T. polium appears to be a potentially effective antineoplastic agent. However, the cytotoxic effect of T. polium on SNU-449 cells is not mediated by induction of apoptosis.
- 23 February 2026
- Published by Springer Nature in Research Square
Open AccessCytotoxic and Apoptotic Effects of Teucrium Polium L Extract on Human Hepatocellular Carcinoma Cell Line SNU-449
Purpose : The current study aims to evaluate the effects of T. polium extract on the human HCC cell line SNU-449 in vitro and to determine possible cytotoxic, apoptotic and anti-cancer properties. Methods : The MTT assay was performed to determine the dose-dependent effects of T. polium on tumor cell proliferation and to calculate IC50. The colony formation assay was carried out using the IC50 dose of T. polium to evaluate its effects on colony formation. To study the effect of T. polium on in vitro migration of SNU-449 cells, the scratch assay was performed. Finally, Western blotting was performed for caspase-3 and cleaved caspase-3 to study possible apoptotic effects. Results : MTT analysis results demonstrated a dose-dependent decrease in cell viability. IC50 was calculated as 90 μg/mL using measurements from the 48th hour results. The colony formation assay showed that colony formation efficiency was reduced by 50% among SNU-449 cells in the T. polium treated group. With the wound healing assay results, half-gap times for the T. polium treated group and the control group were determined as 50.5 and 28.5 hours, respectively. Comparison of the caspase-3 and cleaved caspase-3 levels measured in T. polium treated cells and control cells by means of Western blotting did not demonstrate a significant difference between the two groups. Conclusion : Reducing proliferation and survival rates in SNU-449 cells, T. polium appears to be a potentially effective antineoplastic agent. However, the cytotoxic effect of T. polium on SNU-449 cells is not mediated by induction of apoptosis.
- Open Access
- 18 February 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (2) , 320
Local ADSC Delivery Methods Accelerate Healing of Large Unburned Full-Thickness Skin Defects by Promoting an Optimal Wound Microenvironment
Background: This study introduces an experimental model of a large, full-thickness skin defect and evaluates how adipose-derived stem cells characterized by high self-renewal and differentiation capacity affect both wound healing and the wound microenvironment when delivered using two different local application methods. Materials and Methods: In this preclinical study, we established an excisional full-thickness skin defect model involving approximately 30% of the total body surface area (TBSA). Five experimental groups were formed, each containing equal numbers of male and female rats: (1) subdermal ADSC injection (ADSC-I) (n = 8), (2) application of an acellular dermal matrix (ADM) seeded with ADSCs (n = 8) (ADSC-ADM), (3) ADM alone (n = 8), (4) subdermal saline injection (n = 8) (SS-I), and (5) an untreated skin-defect sham group (n = 8). Wound healing and wound microenvironment parameters were assessed at regular intervals using macroscopic and microscopic evaluations, as well as various quantitative measurements. The study was terminated when complete wound closure was achieved in all animals of at least one experimental group. Results: The most favorable healing outcomes were observed in the two ADSC-treated groups. More favorable microenvironmental conditions in the stem cell groups were detected from day 14 onward. Complete closure of the dermal defects occurred by day 32 in the ADSC-I group, whereas none of the other groups achieved full wound closure within the study period. Conclusions: Local application of adipose-derived stem cells may accelerate wound healing by favorably modulating the wound microenvironment.
- 18 February 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (2) , 320
Open AccessLocal ADSC Delivery Methods Accelerate Healing of Large Unburned Full-Thickness Skin Defects by Promoting an Optimal Wound Microenvironment
Background: This study introduces an experimental model of a large, full-thickness skin defect and evaluates how adipose-derived stem cells characterized by high self-renewal and differentiation capacity affect both wound healing and the wound microenvironment when delivered using two different local application methods. Materials and Methods: In this preclinical study, we established an excisional full-thickness skin defect model involving approximately 30% of the total body surface area (TBSA). Five experimental groups were formed, each containing equal numbers of male and female rats: (1) subdermal ADSC injection (ADSC-I) (n = 8), (2) application of an acellular dermal matrix (ADM) seeded with ADSCs (n = 8) (ADSC-ADM), (3) ADM alone (n = 8), (4) subdermal saline injection (n = 8) (SS-I), and (5) an untreated skin-defect sham group (n = 8). Wound healing and wound microenvironment parameters were assessed at regular intervals using macroscopic and microscopic evaluations, as well as various quantitative measurements. The study was terminated when complete wound closure was achieved in all animals of at least one experimental group. Results: The most favorable healing outcomes were observed in the two ADSC-treated groups. More favorable microenvironmental conditions in the stem cell groups were detected from day 14 onward. Complete closure of the dermal defects occurred by day 32 in the ADSC-I group, whereas none of the other groups achieved full wound closure within the study period. Conclusions: Local application of adipose-derived stem cells may accelerate wound healing by favorably modulating the wound microenvironment.
- Open Access
- 19 December 2025
- Published by İnönü Üniversitesi-Eczacılık Fakültesi in Anatolian Journal of Pharmaceutical Sciences
- Vol. 4 (3) , 150-165
Examination Of The Protective Efficiency Of The Fruit Extract And Fruit Vinegar Of The Hawthorn (Crataegus Tanacetifolia) Plant Against Hyperlipidemia And Possible Endothelial Damage In An Experimentally Induced Model Of Hyperlipidemia In Rats
Atherosclerosis is one of the leading causes of death in humans worldwide. Hyperlipidaemia is a significant risk factor for atherosclerosis and is characterised by accelerated atherosclerosis. However, factors such as homocysteine, adhesion molecules, and low HDL-C levels have been reported to play a role in the development of atherosclerosis and hyperlipidaemia. This study aimed to investigate the effects of hawthorn (Crataegus tanacetifolia) fruit extract and fruit vinegar on total cholesterol (TC), triglycerides (TG), Nitrit (NOx), HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 levels, which are among the factors causing hyperlipidaemia and atherosclerosis. In the study, hawthorn extract (HE) and hawthorn vinegar (HV) were administered by gavage to rats with experimentally induced hyperlipidaemia (HL). Rats were divided into seven groups. The control group was fed a normal diet. Blood samples taken at the beginning of the study and the end of the fourth and eighth weeks were separated, and the levels of TC, TG, NOx, HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 were measured. Our results showed that adding HE or HV to the diet reduced homocysteine, P-selectin, TC, LDL-C, NOx and TG levels and increased HDL-C levels. In conclusion, the results of this study, in which we hypothesised that hawthorn fruit extract and fruit vinegar may reduce the risk of atherosclerosis, which increases in correlation with hyperlipidaemia, hypercholesterolaemia, hyperhomocysteinemia and increased levels of adhesion molecules caused by a high-fat diet, showed that hawthorn fruit extract had a strong antiatherogenic effect
- 19 December 2025
- Published by İnönü Üniversitesi-Eczacılık Fakültesi in Anatolian Journal of Pharmaceutical Sciences
- Vol. 4 (3) , 150-165
Open AccessExamination Of The Protective Efficiency Of The Fruit Extract And Fruit Vinegar Of The Hawthorn (Crataegus Tanacetifolia) Plant Against Hyperlipidemia And Possible Endothelial Damage In An Experimentally Induced Model Of Hyperlipidemia In Rats
Atherosclerosis is one of the leading causes of death in humans worldwide. Hyperlipidaemia is a significant risk factor for atherosclerosis and is characterised by accelerated atherosclerosis. However, factors such as homocysteine, adhesion molecules, and low HDL-C levels have been reported to play a role in the development of atherosclerosis and hyperlipidaemia. This study aimed to investigate the effects of hawthorn (Crataegus tanacetifolia) fruit extract and fruit vinegar on total cholesterol (TC), triglycerides (TG), Nitrit (NOx), HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 levels, which are among the factors causing hyperlipidaemia and atherosclerosis. In the study, hawthorn extract (HE) and hawthorn vinegar (HV) were administered by gavage to rats with experimentally induced hyperlipidaemia (HL). Rats were divided into seven groups. The control group was fed a normal diet. Blood samples taken at the beginning of the study and the end of the fourth and eighth weeks were separated, and the levels of TC, TG, NOx, HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 were measured. Our results showed that adding HE or HV to the diet reduced homocysteine, P-selectin, TC, LDL-C, NOx and TG levels and increased HDL-C levels. In conclusion, the results of this study, in which we hypothesised that hawthorn fruit extract and fruit vinegar may reduce the risk of atherosclerosis, which increases in correlation with hyperlipidaemia, hypercholesterolaemia, hyperhomocysteinemia and increased levels of adhesion molecules caused by a high-fat diet, showed that hawthorn fruit extract had a strong antiatherogenic effect
- Open Access
- 18 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8970
Prospective Analysis of Perioperative Stress Response in Living Donor Liver Transplantation for Hepatitis B-Related Liver Disease
Background: Liver transplantation is a life-saving procedure for patients with end-stage liver disease, yet the immunological consequences of surgical trauma in these patients are not fully understood. The liver plays a central role in immune regulation, and its dysfunction in HBV-related chronic liver disease may alter the systemic stress response to surgery. Aim: This study aims to evaluate the stress response to surgical trauma of patients undergoing living donor liver transplantation (LDLT) for HBV-related chronic liver disease in comparison to living liver donors (LLDs). Methods: This prospective study included 20 LDLT recipients with HBV infection and 20 LLDs who underwent living donor hepatectomy between August 2020 and February 2021. Specific biochemical markers (IL-1, IL-4, IL-6, IL-22, IFN-γ, TNF-α, TGF-β, GM-CSF, GLDH, and GalactB) were measured at designated intervals: preoperative day 0 (Preop), immediately after incision (Incision), post-hepatectomy (Hepatectomy), postoperative day 0 (POD0), POD1, and POD3 using enzyme-linked immunosorbent assay (ELISA). Routine hematological and biochemical parameters (WBC, HGB, PLT, RDW, MPV, PDW, AST, ALT, ALP, GGT, albumin, total bilirubin, plateletcrit, phosphorus, fibrinogen, and INR) were measured regularly at five predetermined times: Preop, POD0, POD1, POD2, and POD3. Results: Prior to LDLT, LDLT recipients had significantly lower levels of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, IFN-γ) compared to LLDs (p < 0.05). However, following liver implantation, these cytokine levels increased significantly at POD0, POD1, and POD3 (p < 0.001). Specifically, IL-1 levels elevated from 0 in the preop period to 21.5 (97.5) in POD3, and IL-6 elevated from 0 in the preop period to 28.3 at POD3 (p = 0.056). Similarly, TNF-α and IFN-γ levels exhibited significant upward trends (p < 0.05). In contrast, cytokine levels in LLDs remained stable throughout the perioperative period, revealing no statistically significant variations (p > 0.05). Routine hematological and biochemical parameters demonstrated significant postoperative fluctuations in LDLT recipients, reflecting the metabolic and immune restoration process. Conclusions: These findings indicate that patients with HBV-related chronic liver disease exhibit a diminished stress response to trauma due to underlying immune dysregulation caused by chronic hepatic dysfunction. However, after LDLT, the stress response gradually normalizes, suggesting that liver transplantation not only restores hepatic function but also reestablishes immune homeostasis, potentially reducing infection risks and improving postoperative recovery. These findings emphasize the crucial role of the liver in regulating the body’s stress response to trauma and highlight the immunological benefits of LDLT in restoring immune homeostasis.
- 18 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8970
Open AccessProspective Analysis of Perioperative Stress Response in Living Donor Liver Transplantation for Hepatitis B-Related Liver Disease
Background: Liver transplantation is a life-saving procedure for patients with end-stage liver disease, yet the immunological consequences of surgical trauma in these patients are not fully understood. The liver plays a central role in immune regulation, and its dysfunction in HBV-related chronic liver disease may alter the systemic stress response to surgery. Aim: This study aims to evaluate the stress response to surgical trauma of patients undergoing living donor liver transplantation (LDLT) for HBV-related chronic liver disease in comparison to living liver donors (LLDs). Methods: This prospective study included 20 LDLT recipients with HBV infection and 20 LLDs who underwent living donor hepatectomy between August 2020 and February 2021. Specific biochemical markers (IL-1, IL-4, IL-6, IL-22, IFN-γ, TNF-α, TGF-β, GM-CSF, GLDH, and GalactB) were measured at designated intervals: preoperative day 0 (Preop), immediately after incision (Incision), post-hepatectomy (Hepatectomy), postoperative day 0 (POD0), POD1, and POD3 using enzyme-linked immunosorbent assay (ELISA). Routine hematological and biochemical parameters (WBC, HGB, PLT, RDW, MPV, PDW, AST, ALT, ALP, GGT, albumin, total bilirubin, plateletcrit, phosphorus, fibrinogen, and INR) were measured regularly at five predetermined times: Preop, POD0, POD1, POD2, and POD3. Results: Prior to LDLT, LDLT recipients had significantly lower levels of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, IFN-γ) compared to LLDs (p < 0.05). However, following liver implantation, these cytokine levels increased significantly at POD0, POD1, and POD3 (p < 0.001). Specifically, IL-1 levels elevated from 0 in the preop period to 21.5 (97.5) in POD3, and IL-6 elevated from 0 in the preop period to 28.3 at POD3 (p = 0.056). Similarly, TNF-α and IFN-γ levels exhibited significant upward trends (p < 0.05). In contrast, cytokine levels in LLDs remained stable throughout the perioperative period, revealing no statistically significant variations (p > 0.05). Routine hematological and biochemical parameters demonstrated significant postoperative fluctuations in LDLT recipients, reflecting the metabolic and immune restoration process. Conclusions: These findings indicate that patients with HBV-related chronic liver disease exhibit a diminished stress response to trauma due to underlying immune dysregulation caused by chronic hepatic dysfunction. However, after LDLT, the stress response gradually normalizes, suggesting that liver transplantation not only restores hepatic function but also reestablishes immune homeostasis, potentially reducing infection risks and improving postoperative recovery. These findings emphasize the crucial role of the liver in regulating the body’s stress response to trauma and highlight the immunological benefits of LDLT in restoring immune homeostasis.
- Open Access
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 281-290
Oleuropein changes the biological characteristics of the HepG2 cells by regulating the IL-6 / STAT3 pathway
Aim: Oleuropein (Ole) possesses a wide array of pharmacological benefits. Despite Ole's well-established anti-inflammatory and anti-tumor effects, there remains a gap in the research concerning its specific mechanism of action. We aimed to evaluate the effects of Ole treatment on various characteristics, such as the viability of the cells, wound healing, colony formation, and the protein levels of the IL-6 / STAT3 pathway were evaluated in vitro in HepG2 HCC cells. Methods: Cell viability, wound healing, and colony formation assays were performed. IL-6 levels measurement by ELISA, STAT3, and pSTAT3 protein expression measurement by Western blotting were performed in Ole-treated HepG2 cells. Results: Following the treatment of cells with Ole, there was a dose-dependent reduction in the viability of the cells and wound healing parameters. Colony formation was completely inhibited compared to control cells. Although IL-6 and STAT3 levels were strongly suppressed in Ole-treated cells compared to control cells, this difference did not achieve a statistical significance. Only pSTAT3 expression in Ole100-treated cells was significantly downregulated compared to control cells. Conclusion: Based on our study, Ole treatment seems to have an impact on the characteristics of HCC cells through its effect on increased cell death, reduced cell migration, and the downregulation of the IL-6 / STAT3 pathway.
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 281-290
Open AccessOleuropein changes the biological characteristics of the HepG2 cells by regulating the IL-6 / STAT3 pathway
Aim: Oleuropein (Ole) possesses a wide array of pharmacological benefits. Despite Ole's well-established anti-inflammatory and anti-tumor effects, there remains a gap in the research concerning its specific mechanism of action. We aimed to evaluate the effects of Ole treatment on various characteristics, such as the viability of the cells, wound healing, colony formation, and the protein levels of the IL-6 / STAT3 pathway were evaluated in vitro in HepG2 HCC cells. Methods: Cell viability, wound healing, and colony formation assays were performed. IL-6 levels measurement by ELISA, STAT3, and pSTAT3 protein expression measurement by Western blotting were performed in Ole-treated HepG2 cells. Results: Following the treatment of cells with Ole, there was a dose-dependent reduction in the viability of the cells and wound healing parameters. Colony formation was completely inhibited compared to control cells. Although IL-6 and STAT3 levels were strongly suppressed in Ole-treated cells compared to control cells, this difference did not achieve a statistical significance. Only pSTAT3 expression in Ole100-treated cells was significantly downregulated compared to control cells. Conclusion: Based on our study, Ole treatment seems to have an impact on the characteristics of HCC cells through its effect on increased cell death, reduced cell migration, and the downregulation of the IL-6 / STAT3 pathway.
- Open Access
The Effect of Pringle Maneuver Applied during Living Donor Hepatectomy on the Ischemia-Reperfusion Injury Observed in the Donors and Recipients
Background and Objectives: The aim of this study is to evaluate the clinical and laboratory changes of ischemia and reperfusion injury in the remnant livers of donors with and without Pringle maneuver. Furthermore, we evaluated the recipients who have been transplanted with liver grafts from these donors. Methods and Materials: A total of 108 patients (54 living liver donors and 54 liver recipients) who underwent donor hepatectomy and recipients who living donor liver transplantation, were included in this randomized double-blind study between February 2021 and June 2021. The donors were divided into two groups: Pringle maneuver applied (n = 27) and Pringle maneuver not applied (n = 27). Similarly, recipients with implanted liver obtained from these donors were divided into two groups as the Pringle maneuver was performed (n = 27) and not performed (n = 27). Blood samples from donors and recipients were obtained on pre-operative, post-operative 0 h day (day of surgery), post-operative 1st day, post-operative 2nd day, post-operative 3rd day, post-operative 4th day, post-operative 5th day, and liver tissue was taken from the graft during the back table procedures. Liver function tests and complete blood count, coagulation tests, IL-1, IL-2, IL-6, TNF-α, and β-galactosidase measurements, and histopathological findings were examined. Results: There was no statistically significant difference in the parameters of biochemical analyses for ischemia-reperfusion injury at all periods in the donors with and without the Pringle maneuver. Similarly, there was no statistically significant difference between in the recipients in who received liver grafts harvested with and without the Pringle maneuver. There was no statistically significant difference between the two recipient groups in terms of perioperative bleeding and early bile duct complications (p = 0.685). In the histopathological examinations, hepatocyte damage was significantly higher in the Pringle maneuver group (p = 0.001). Conclusions: Although the histological scoring of hepatocyte damage was found to be higher in the Pringle maneuver group, the Pringle maneuver did not augment ischemia-reperfusion injury in donors and recipients that was evaluated by clinical and laboratory analyses.
Open AccessThe Effect of Pringle Maneuver Applied during Living Donor Hepatectomy on the Ischemia-Reperfusion Injury Observed in the Donors and Recipients
Background and Objectives: The aim of this study is to evaluate the clinical and laboratory changes of ischemia and reperfusion injury in the remnant livers of donors with and without Pringle maneuver. Furthermore, we evaluated the recipients who have been transplanted with liver grafts from these donors. Methods and Materials: A total of 108 patients (54 living liver donors and 54 liver recipients) who underwent donor hepatectomy and recipients who living donor liver transplantation, were included in this randomized double-blind study between February 2021 and June 2021. The donors were divided into two groups: Pringle maneuver applied (n = 27) and Pringle maneuver not applied (n = 27). Similarly, recipients with implanted liver obtained from these donors were divided into two groups as the Pringle maneuver was performed (n = 27) and not performed (n = 27). Blood samples from donors and recipients were obtained on pre-operative, post-operative 0 h day (day of surgery), post-operative 1st day, post-operative 2nd day, post-operative 3rd day, post-operative 4th day, post-operative 5th day, and liver tissue was taken from the graft during the back table procedures. Liver function tests and complete blood count, coagulation tests, IL-1, IL-2, IL-6, TNF-α, and β-galactosidase measurements, and histopathological findings were examined. Results: There was no statistically significant difference in the parameters of biochemical analyses for ischemia-reperfusion injury at all periods in the donors with and without the Pringle maneuver. Similarly, there was no statistically significant difference between in the recipients in who received liver grafts harvested with and without the Pringle maneuver. There was no statistically significant difference between the two recipient groups in terms of perioperative bleeding and early bile duct complications (p = 0.685). In the histopathological examinations, hepatocyte damage was significantly higher in the Pringle maneuver group (p = 0.001). Conclusions: Although the histological scoring of hepatocyte damage was found to be higher in the Pringle maneuver group, the Pringle maneuver did not augment ischemia-reperfusion injury in donors and recipients that was evaluated by clinical and laboratory analyses.
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Pteridines
- Vol. 35 (1)
The role of neopterin in cross-talk between tumor and tumor microenvironment in hepatocellular carcinoma
Neopterin is a marker of activated immune response, but its role in hepatocarcinogenesis is unknown. The present study aims to evaluate the effects of neopterin on prooncogenic/proinflammatory, apoptotic pathways, and other molecular mechanisms in HCC. We used SNU449, Huh-7, SK-Hep-1, and HepG2 cell lines. A cell viability assay was performed with different concentrations of neopterin. RT-PCR, Western blotting, transwell migration, scratch assay, and reactive oxygen species (ROS) production assays were performed at inhibition concentration 50 of neopterin, which was 40 µM for SNU449 and 80 µM for other cell lines. There were significant changes in mTOR, STAT3, PI3K, and interleukin-6 gene expressions, which were also supported by the protein expressions. Neopterin did not affect apoptosis in SNU449, while apoptosis increased by all doses of neopterin in SK-Hep-1 and HepG2. ROS production was increased in all cell lines in response to neopterin. Cell migration was reduced in SK-Hep1 and HepG2 but did not change in SNU449 and Huh-7. Our study showed that neopterin is not just a byproduct. The results suggest that neopterin may be a paracrine factor that modulates pro-inflammatory and pro-oncogenic pathways responsible for the biological behavior of HCC in a chronic inflammatory tumor microenvironment.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Pteridines
- Vol. 35 (1)
Open AccessThe role of neopterin in cross-talk between tumor and tumor microenvironment in hepatocellular carcinoma
Neopterin is a marker of activated immune response, but its role in hepatocarcinogenesis is unknown. The present study aims to evaluate the effects of neopterin on prooncogenic/proinflammatory, apoptotic pathways, and other molecular mechanisms in HCC. We used SNU449, Huh-7, SK-Hep-1, and HepG2 cell lines. A cell viability assay was performed with different concentrations of neopterin. RT-PCR, Western blotting, transwell migration, scratch assay, and reactive oxygen species (ROS) production assays were performed at inhibition concentration 50 of neopterin, which was 40 µM for SNU449 and 80 µM for other cell lines. There were significant changes in mTOR, STAT3, PI3K, and interleukin-6 gene expressions, which were also supported by the protein expressions. Neopterin did not affect apoptosis in SNU449, while apoptosis increased by all doses of neopterin in SK-Hep-1 and HepG2. ROS production was increased in all cell lines in response to neopterin. Cell migration was reduced in SK-Hep1 and HepG2 but did not change in SNU449 and Huh-7. Our study showed that neopterin is not just a byproduct. The results suggest that neopterin may be a paracrine factor that modulates pro-inflammatory and pro-oncogenic pathways responsible for the biological behavior of HCC in a chronic inflammatory tumor microenvironment.
- 4 October 2023
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Phenethyl isothiocyanate Regulates the Cancer Stem Cell Phenotype of SNU449 Hepatocellular Carcinoma Cells via STAT3-CD44 Axis
Cancer stem cells play an important role in resistance to therapy, invasion, metastasis, and recurrence. CD44 is one of the well-known surface markers for hepatocellular carcinoma and its expression level is related to poor survival and a high recurrence rate. The effect of phenethyl isothiocyanate (PEITC) on SNU449 hepatocellular carcinoma cell line cancer stem cells is not known. The goal of the present study was to investigate whether PEITC regulates the cancer stem cell phenotype of SNU449 cells. Here, cell viability, colony formation, and wound healing assays were performed to determine proliferative and migratory characteristics. Additionally, Caspase 3, CD44, Akt/mTOR, and p38/STAT3 protein expression levels were measured by western blotting. We found that compared to control confluence, gap fill, and migration rate were increased while half gap time was decreased in PEITC-treated cells. Compared to control-treated cells CD44 (3.2 fold) and p-STAT3 (2.44 fold) protein expressions were upregulated in PEITC-treated cells. Results of this study suggest that STAT3-mediated upregulation of CD44 leads to the gain of cancer stem cell phenotype of PEITC-treated SNU449 cells.
- 4 October 2023
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Phenethyl isothiocyanate Regulates the Cancer Stem Cell Phenotype of SNU449 Hepatocellular Carcinoma Cells via STAT3-CD44 Axis
Cancer stem cells play an important role in resistance to therapy, invasion, metastasis, and recurrence. CD44 is one of the well-known surface markers for hepatocellular carcinoma and its expression level is related to poor survival and a high recurrence rate. The effect of phenethyl isothiocyanate (PEITC) on SNU449 hepatocellular carcinoma cell line cancer stem cells is not known. The goal of the present study was to investigate whether PEITC regulates the cancer stem cell phenotype of SNU449 cells. Here, cell viability, colony formation, and wound healing assays were performed to determine proliferative and migratory characteristics. Additionally, Caspase 3, CD44, Akt/mTOR, and p38/STAT3 protein expression levels were measured by western blotting. We found that compared to control confluence, gap fill, and migration rate were increased while half gap time was decreased in PEITC-treated cells. Compared to control-treated cells CD44 (3.2 fold) and p-STAT3 (2.44 fold) protein expressions were upregulated in PEITC-treated cells. Results of this study suggest that STAT3-mediated upregulation of CD44 leads to the gain of cancer stem cell phenotype of PEITC-treated SNU449 cells.
- Open Access
Assessment of Liver Regeneration in Patients Who Have Undergone Living Donor Hepatectomy for Living Donor Liver Transplantation
Background: Inflammation and the associated immune pathways are among the most important factors in liver regeneration after living donor hepatectomy. Various biomarkers, especially liver function tests, are used to show liver regeneration. The aim of this study was to evaluate the course of liver regeneration following donor hepatectomy (LDH) by routine and regeneration-related biomarkers. Method: Data from 63 living liver donors (LLDs) who underwent LDH in Inonu University Liver Transplant Institute were prospectively analyzed. Serum samples were obtained on the preoperative day and postoperative days (POD) 1, 3, 5, 10, and 21. Regenerative markers including alfa-fetoprotein (AFP), des carboxy prothrombin (DCP), ornithine decarboxylase (ODC), retinol-binding protein 4 (RBP4), and angiotensin-converting enzyme isotype II (ACEII) and liver function tests including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) and total bilirubin levels were all analyzed. Results: The median age of the LLDs was 29.7 years and 28 LLDs were female. Eight LLDs developed postoperative complications requiring relaparotomy. The routine laboratory parameters including AST (p = 0.006), AFP (p = 0.002), DCP (p = 0.007), and ODC (p = 0.002) showed a significant increase in POD3. The regeneration parameters showed a different pattern of change. In right-lobe liver grafts, ACEII (p = 0.002), AFP (p = 0.035), and ODC (p = 0.001) showed a significant increase over time. DCP (p = 0.129) and RBP4 (p = 0.335) showed no significant changes in right-lobe liver grafts. Conclusions: Regenerative markers are increased in a sustained fashion following LDH. This is more prominent following right-lobe grafts which are indicative of progenitor-associated liver regeneration.
Open AccessAssessment of Liver Regeneration in Patients Who Have Undergone Living Donor Hepatectomy for Living Donor Liver Transplantation
Background: Inflammation and the associated immune pathways are among the most important factors in liver regeneration after living donor hepatectomy. Various biomarkers, especially liver function tests, are used to show liver regeneration. The aim of this study was to evaluate the course of liver regeneration following donor hepatectomy (LDH) by routine and regeneration-related biomarkers. Method: Data from 63 living liver donors (LLDs) who underwent LDH in Inonu University Liver Transplant Institute were prospectively analyzed. Serum samples were obtained on the preoperative day and postoperative days (POD) 1, 3, 5, 10, and 21. Regenerative markers including alfa-fetoprotein (AFP), des carboxy prothrombin (DCP), ornithine decarboxylase (ODC), retinol-binding protein 4 (RBP4), and angiotensin-converting enzyme isotype II (ACEII) and liver function tests including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) and total bilirubin levels were all analyzed. Results: The median age of the LLDs was 29.7 years and 28 LLDs were female. Eight LLDs developed postoperative complications requiring relaparotomy. The routine laboratory parameters including AST (p = 0.006), AFP (p = 0.002), DCP (p = 0.007), and ODC (p = 0.002) showed a significant increase in POD3. The regeneration parameters showed a different pattern of change. In right-lobe liver grafts, ACEII (p = 0.002), AFP (p = 0.035), and ODC (p = 0.001) showed a significant increase over time. DCP (p = 0.129) and RBP4 (p = 0.335) showed no significant changes in right-lobe liver grafts. Conclusions: Regenerative markers are increased in a sustained fashion following LDH. This is more prominent following right-lobe grafts which are indicative of progenitor-associated liver regeneration.